RESUMEN
Abstract Traumatic brain injury (TBI) increases the risk of neuropsychiatric disorders, particularly anxiety disorders. Yet, there are presently no therapeutic interventions to prevent the development of post-traumatic anxiety or effective treatments once it has developed. This is because, in large part, of a lack of understanding of the underlying pathophysiology. Recent research suggests that chronic neuroinflammatory responses to injury may play a role in the development of post-traumatic anxiety in rodent models. Acute peri-injury administration of immunosuppressive compounds, such as Ibudilast (MN166), have been shown to prevent reactive gliosis associated with immune responses to injury and also prevent lateral fluid percussion injury (LFPI)-induced anxiety-like behavior in rats. There is evidence in both human and rodent studies that post-traumatic anxiety, once developed, is a chronic, persistent, and drug-refractory condition. In the present study, we sought to determine whether neuroinflammation is associated with the long-term maintenance of post-traumatic anxiety. We examined the efficacy of an anti-inflammatory treatment in decreasing anxiety-like behavior and reactive gliosis when introduced at 1 month after injury. Delayed treatment substantially reduced established LFPI-induced freezing behavior and reactive gliosis in brain regions associated with anxiety and continued neuroprotective effects were evidenced 6 months post-treatment. These results support the conclusion that neuroinflammation may be involved in the development and maintenance of anxiety-like behaviors after TBI.
Asunto(s)
Ansiedad/tratamiento farmacológico , Conducta Animal/efectos de los fármacos , Lesiones Encefálicas/tratamiento farmacológico , Reacción Cataléptica de Congelación/efectos de los fármacos , Inmunosupresores/uso terapéutico , Piridinas/uso terapéutico , Animales , Ansiedad/etiología , Lesiones Encefálicas/complicaciones , Modelos Animales de Enfermedad , Gliosis/tratamiento farmacológico , Gliosis/etiología , Inmunosupresores/farmacología , Masculino , Actividad Motora/efectos de los fármacos , Piridinas/farmacología , Ratas , Resultado del TratamientoRESUMEN
Stimulating sensitized immune cells with a subsequent immune challenge results in potentiated pro-inflammatory responses translating into exacerbated sickness responses (i.e. fever, pain and lethargy). Both corticosterone (CORT) and laparotomy cause sensitization, leading to enhanced sickness-induced neuroinflammation or pain (respectively). However, it is unknown whether this sensitization affects all sickness behaviors and immune cell responses equally. We show that prior CORT and prior laparotomy potentiated LPS-induced fever but not lethargy. Prior CORT, like prior laparotomy, was able to potentiate sickness-induced pain. Release of nitric oxide (NO) from peritoneal macrophages stimulated ex vivo demonstrates that laparotomy, but not CORT sensitizes these cells.
Asunto(s)
Corticosterona/administración & dosificación , Corticosterona/toxicidad , Fiebre/inducido químicamente , Infecciones por Bacterias Gramnegativas/inducido químicamente , Laparotomía/efectos adversos , Lipopolisacáridos/administración & dosificación , Lipopolisacáridos/toxicidad , Animales , Conducta Animal/efectos de los fármacos , Células Cultivadas , Sinergismo Farmacológico , Fiebre/inmunología , Fiebre/patología , Infecciones por Bacterias Gramnegativas/inmunología , Infecciones por Bacterias Gramnegativas/patología , Interacciones Huésped-Patógeno/inmunología , Inmunización , Inflamación/inducido químicamente , Inflamación/inmunología , Inflamación/patología , Macrófagos Peritoneales/efectos de los fármacos , Macrófagos Peritoneales/inmunología , Macrófagos Peritoneales/patología , Masculino , Dolor/inducido químicamente , Dolor/inmunología , Dolor/patología , Ratas , Ratas Sprague-DawleyRESUMEN
Fever is a critical component of the host immune response to infection. An emerging literature demonstrates that experience with infectious organisms early in life, during the perinatal period, may permanently program immune responses later in life, including fever. We explored the influence of neonatal infection with Escherichia coli on fever responses to lipopolysaccharide (LPS) and E. coli in adulthood. Fever to a low dose of LPS in adulthood did not significantly differ as a consequence of early-life infection. Eight days after the LPS injection, the same group of rats received a high dose of live E. coli. This time, neonatally infected rats exhibited a markedly longer fever than controls. In a subsequent experiment, fever to a single high dose of E. coli without prior LPS in adulthood did not differ by group, suggesting that the previous difference was a lack of tolerance to the dual challenges in early-infected rats. Finally, both groups exhibited decreased tumor necrosis factor (TNF)-alpha and toll-like-receptor (TLR) 4 production to dual LPS challenges in isolated splenocytes, whereas only rats infected as neonates exhibited increased cyclooxygenase-2 within the hypothalamus in response to adult infection, suggesting that early infection-induced changes in fever regulation may involve a change in central mechanisms. Taken together, these data indicate that early-life infection is associated with marked changes in host temperature regulation in adulthood.
Asunto(s)
Infecciones Bacterianas/inmunología , Fiebre , Tolerancia Inmunológica/fisiología , Lipopolisacáridos/farmacología , Factores de Edad , Animales , Animales Recién Nacidos , Infecciones Bacterianas/complicaciones , Infecciones Bacterianas/genética , Infecciones Bacterianas/fisiopatología , Ciclooxigenasa 2/genética , Ciclooxigenasa 2/metabolismo , Escherichia coli/inmunología , Infecciones por Escherichia coli/complicaciones , Infecciones por Escherichia coli/genética , Infecciones por Escherichia coli/inmunología , Infecciones por Escherichia coli/fisiopatología , Femenino , Fiebre/inducido químicamente , Fiebre/etiología , Fiebre/genética , Fiebre/inmunología , Tolerancia Inmunológica/efectos de los fármacos , Tolerancia Inmunológica/genética , Memoria Inmunológica/efectos de los fármacos , Memoria Inmunológica/fisiología , Inflamación/inducido químicamente , Inflamación/genética , Inflamación/metabolismo , Masculino , Neuroinmunomodulación/efectos de los fármacos , Neuroinmunomodulación/fisiología , Ratas , Ratas Sprague-Dawley , Pérdida de Peso/efectos de los fármacos , Pérdida de Peso/inmunologíaRESUMEN
Spinal proinflammatory cytokines are powerful pain-enhancing signals that contribute to pain following peripheral nerve injury (neuropathic pain). Recently, one proinflammatory cytokine, interleukin-1, was also implicated in the loss of analgesia upon repeated morphine exposure (tolerance). In contrast to prior literature, we demonstrate that the action of several spinal proinflammatory cytokines oppose systemic and intrathecal opioid analgesia, causing reduced pain suppression. In vitro morphine exposure of lumbar dorsal spinal cord caused significant increases in proinflammatory cytokine and chemokine release. Opposition of analgesia by proinflammatory cytokines is rapid, occurring < or =5 min after intrathecal (perispinal) opioid administration. We document that opposition of analgesia by proinflammatory cytokines cannot be accounted for by an alteration in spinal morphine concentrations. The acute anti-analgesic effects of proinflammatory cytokines occur in a p38 mitogen-activated protein kinase and nitric oxide dependent fashion. Chronic intrathecal morphine or methadone significantly increased spinal glial activation (toll-like receptor 4 mRNA and protein) and the expression of multiple chemokines and cytokines, combined with development of analgesic tolerance and pain enhancement (hyperalgesia, allodynia). Statistical analysis demonstrated that a cluster of cytokines and chemokines was linked with pain-related behavioral changes. Moreover, blockade of spinal proinflammatory cytokines during a stringent morphine regimen previously associated with altered neuronal function also attenuated enhanced pain, supportive that proinflammatory cytokines are importantly involved in tolerance induced by such regimens. These data implicate multiple opioid-induced spinal proinflammatory cytokines in opposing both acute and chronic opioid analgesia, and provide a novel mechanism for the opposition of acute opioid analgesia.